The new guidelines will facilitate the design and development of clinical trials to test new therapies to minimize the burden of neurologic disability produced by neurosarcoidosis.
Your search for major depressive disorder returned 12 results
Click on a filter below to refine your search. Remove a filter to broaden your search.
Depression is one of the most commonly reported complications resulting from stroke.
There are several drug-based and non-pharmacological treatments available that can help reduce symptoms of depression in patients with epilepsy.
Comorbid psychological conditions affect cognitive function in Parkinson’s disease, and treatment can be complicated by overlapping symptoms.
Neuroimaging and if necessary, genetic testing, can help to confirm an FTD diagnosis.
New findings suggest shared genetic etiology vs causal relationship in comorbid migraine and depression.
Medication, plus a relatively sedentary lifestyle, places people with epilepsy at great risk of metabolic syndrome and its various complications.
When first-line therapies fail, physicians must consider several factors when choosing the next course of treatment for their RRMS patients.
Research has shown a confounding link between nicotine and reduced risk of Parkinson’s disease.